key: cord-1032815-cx1zvhq4 authors: Adhikari, Bikash; Marasini, Bishnu P.; Rayamajhee, Binod; Bhattarai, Bibek Raj; Lamichhane, Ganesh; Khadayat, Karan; Adhikari, Achyut; Khanal, Santosh; Parajuli, Niranjan title: Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID‐19: A review date: 2020-10-09 journal: Phytother Res DOI: 10.1002/ptr.6893 sha: 59d077a6bf6b6544658675110584824a6b6e672d doc_id: 1032815 cord_uid: cx1zvhq4 The whole world is entangled by the coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), people are dying in thousands each day, and without an actual medication, it seems not possible for the bringing this global health crisis to a stop. Natural products have been in constant use since ancient times and are proven by time to be effective. Crude extract or pure compounds isolated from medicinal plants and/or herbs such as Artemisia annua, Agastache rugosa, Astragalus membranaceus, Cassia alata, Ecklonia cava, Gymnema sylvestre, Glycyrrhizae uralensis, Houttuynia cordata, Lindera aggregata, Lycoris radiata, Mollugo cerviana, Polygonum multiflorum, Pyrrosia lingua, Saposhnikoviae divaricate, Tinospora cordifolia etc. have shown promising inhibitory effect against coronavirus. Several molecules, including acacetin, amentoflavone, allicin, blancoxanthone, curcumin, daidzein, diosmin, epigallocatechin‐gallate, emodin, hesperidin, herbacetin, hirsutenone, iguesterin, jubanine G, kaempferol, lycorine, pectolinarin, phloroeckol, silvestrol, tanshinone I, taxifolin, rhoifolin, xanthoangelol E, zingerol etc. isolated from plants could also be potential drug candidates against COVID‐19. Moreover, these could also show promising inhibitory effects against influenza‐parainfluenza viruses, respiratory syncytial virus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome coronavirus (MERS‐CoV). Here, we have reported 93 antiviral drug candidates which could be a potential area of research in drug discovery. form the viral capsid that encapsulates the genome and also facilitates the entry process to human cells through the ACE-2 receptor ( Figure 1S in Data S1). Newly emerging viral borne infectious diseases have defied even the survival of humans and other living creatures. Usually, viral diseases are difficult to control and have a more comprehensive public health impact, so viral pathogens like HIV, human influenza, SARS, chikungunya, Ebola, Zika have received more attention and have threatened modern healthcare and pharmaceutical sectors. Many infections and abnormal physiology caused by several viruses belonging to coronavirideae family been reported (Table 1S in Data S1). Till now, there are no absolute therapies for COVID-19, but preventive and supportive therapies are employed to control further complications and organ damage (Rodríguez-Morales, MacGregor, Kanagarajah, Patel, & Schlagenhauf, 2020) . Based on the information available key regions of new drug targets are RNA-dependent RNA polymerase (RdRP) of the virus, cell membrane receptors of SARS-CoV-2 (ACE-2), and spike proteins (S protein), the antiviral mechanism of plant extracts varies as per the structure and replication process of the viruses. Some plants help to increase the inherent antiviral immunity of our body (Webster, Taschereau, Lee, & Jurgens, 2006) . Some of the studies have already proven that plant extracts can be used for the preparation of peptides/proteins with the medicinal value, which can be a good source of vaccines and protein/peptides-based treatment. However, screening of new therapeutic products will take an extended period, and medicinal plants could be an alternative, which is already tested by various ethnic groups since the ancient period. It is believed that medicinal plants are the primary source of healthcare for nearly 85% of the global population (Peši c, 2015) , and more than 40% of synthetic drugs available in pharmaceutical markets are derived from plants and microbial-based natural products (Bauer & Brönstrup, 2014) . In order to find the potent antiviral drug of the COVID-19, research should be directed to emulsion-based uHTS as well for the screening of hundreds of natural products. Thus, this review is focused on summarizing medicinal plants and/or herbs showing antiviral properties, which could be useful in drug discovery programs. The era of antiviral drug development was begun after the approval of idoxuridine in June 1963, which was the first anti-herpes antiviral drug that inhibits viral DNA synthesis (De Clercq, 2004) . Since then, more than 90 drugs of different functional groups have been authorized for the therapeutic purpose of viral diseases, including HIV, HBV, HCV, and influenza virus infections (De Clercq & Li, 2016) . On the other hand, increasing antiviral drug resistance (ADR) like in herpesviruses and HBV is a pressing concern, and ADR could be managed by understanding the mechanism of resistance pattern, formulation of new drugs, optimization of compound delivery, and host components (Manuscript & Implications, ) . High costs and adverse side effects of synthetic drugs, along with the emergence of ADR has demanded the safe and novel antiviral drugs. Herbal extracts have become an exceptional alternative for the formulation of antiviral drugs that can inhibit multiple steps of the virus replication cycle. Furthermore, plant-based antiviral compounds have shown remarkable results even in multiple clinical trials; for instance, anthocyanins (Pour, Fakhri, Asgary, Farzaei, & Echeverría, 2019) . Medicinal plants were investigated for antiviral activity against the different human viruses like HIV, HSV, rabies virus, SARS, MERS, poxvirus, dengue virus, and influenza viruses (Table 2S in Data S1). Nepeta nepetella (150-500 μg/ml), Nepeta coerulea (150-500 μg/ml), Nepeta tuberosa (150-500 μg/ml), Dittrichia viscosa (50-125 μg/ml), and Sanguisorba minor magnolii (50-125 μg/ml), showed an explicit antiviral activity against two different DNA and RNA viruses, that is, HSV-1 and vesicular stomatitis virus (VSV) (Abad, Guerra, Bermejo, Irurzun, & Carrasco, 2000) . Eleutherococcus senticosus roots extract inhibited the replication of RNA viruses such as human rotavirus, RSV, and influenza A virus, but failed to inhibit DNA viruses such as adenovirus and HSV (Glatthaar-Saalmüller, Sacher, & Esperester, 2001) . Azardirachta indica inhibited HSV-1 infection by blocking the entry of the virus to the receptor (glycoprotein) (Tiwari, Darmani, Yue, & Shukla, 2010) . The extracts of Cotoneaster integrifolius and Clinopodium umbrosum, and of Abies spectabilis and Valeriana jatamansi showed moderate activity (IC 50 = 16-20 μg/ml) against HSV-1 and H1N1, respectively (Rajbhandari, Wegner, Jülich, Schöpke, & Mentel, 2001) . Macaranga barteri leaves extract showed antiviral activity with IC 50 of 0.028 and 0.00017 ng/ml against echovirus E7 and E19, respectively (Ogbole, Akinleye, Segun, Faleye, & Adeniji, 2018) . Similarly, Ampelocissus tomentosa (EC 50 = 7.79 μg/ml), Kalanchoe pinnata (EC 50 = 6.1 μg/ml) and Paris polyphylla (EC 50 = 8.74 μg/ml) were active against CHIKV while Clerodendrum serratum (EC 50 = 15.9 μg/ml) and Terminalia chebula (EC 50 = 10.6 μg/ml) were active against yellow fever virus and enterovirus A71, respectively (Joshi et al., 2020) . Amomurn villosum Lour, (Li et al., 2005) . In a study reported by Li et al. (2005) , herbal extracts obtained from four different plants Artemisia annua, Lindera aggregata, Pyrrosia lingua, and Lycoris radiata have shown remarkable antiviral activity in a cell-based stay against the SARS-CoV where the alkaloid, lycorine (1) (Figure 2a) from L. radiata has shown effective inhibitory activity to stop the infection caused by SARS-CoV on HepG2 and Vero E6 cells culture (Li et al., 2005) . Similarly, plant-based phenolic compounds have shown anti-SARS-CoV activity in the cell-based study (C.-W. Lin et al., 2005) . Another study reported by Lau et al. (2008) has shown that the extract of Houttuynia cordata is safe and effective for the treatment of pneumonia caused by SARS-CoV (Lau et al., 2008) . from Achyrocline satureioides inhibit the protein HIV integrase essential for viral DNA integration into host chromatin (Khaerunnisa et al., 2020; Robinson, Reinecke, Abdel-Malek, Jia, & Chow, 1996) . Coronavirus genome encodes a protein called RNA-dependent RNA polymerase (RdRP), which allows the viral genome to be transcribed into new RNA copies using the host cell's machinery. Thus, inhibition of RdRP could be a potential target for the control of viral infection. Epigallocatechin-3-gallate (11), calanolide A (65), and baicalin (66) ( Figure 2e ) inhibit virus replication (Kitazato, Wang, & Kobayashi, 2007 Acacetin ( There are various methods available for in vivo and in vitro screening of extracts of medicinal plants. Notably, this review focused on a little known method in the area of medicinal chemistry, which is mostly known as emulsion-based in vitro compartmentalization (IVC) technique (Gianella, Snapp, & Levy, 2016) . For this purpose, a "water-inoil-in-water" emulsion is used in the compartmentalization of droplets for ultrahigh throughput screening (uHTS). Usually, IVC uses aqueous droplets that contain DNA and machinery for protein production within water-in-oil emulsions (Rothe, Surjadi, & Power, 2006) . (Bernath et al., 2004) . Reprogramming of similar techniques could be explored to study the inhibition of viral protease. Different cell cultures assays, chips-based methods, animal models, and enzyme inhibition assays have been carried to find potent antiviral compounds from natural sources (Anani et al., 2000; Lloyd, Russell, Blanes, Doble, & Roux, 2013; Mukhtar et al., 2008; Ogbole, Segun, & Adeniji, 2017) . Additionally, for a couple of decades, the analysis, process, and development of herbal ingredients have dramatically increased with innovation in laboratory techniques and instrumentation (Fitzgerald, Heinrich, & Booker, 2020) . infected patients was investigated but clinical use has not commenced yet. Except earmarking on viral protease, replication, spike protein, and receptor, its protein kinase C and helicase have also been established as potential targets to inhibit SARS-CoV (Hoever et al., 2005; Jang et al., 2020) . Glycyrrhizin has been revealed as a potential inhibitor of SARS CoV protein kinase C and similarly, myricetin and scutellarein as aptitude inhibitor of viral helicase (Xian et al., 2020) . Herbal-based antiviral medicines have shown promising inhibitory effects, which range from anti-influenza to anti-dengue properties (Table 1 ). In the context of the global burden of COVID-19, where an absolute medicine is waiting for patients, promptly available plantbased medicines with studied safety and efficacy can be on the frontline to tackle the ongoing calamity caused by COVID-19. The problems encountered while using bioactive secondary metabolites like their solubility, stability, and bioavailability need to be addressed to use these metabolites as medicine (Coimbra et al., 2011) . Moreover, the application of artificial intelligence tools like molecular docking studies, toxicity analysis, and pharmacological studies would further add significant information regarding potency of the aforementioned secondary metabolites. However, the mutation occurring in targets should be taken into account. Extensive studies and investments are demanding for new drug development strategies using herbal extracts to save sapiens lives on our planet from pandemics like COVID-19, today, and tomorrow. There are barely any countries that are left untouched by the COVID-19 pandemic. It is one of the greatest public health threats T A B L E 1 Possible antiviral drug candidates from natural products Scutellaria baicalensis Georgi Isoscutellarein (76) Influenza virus (Nagai, Miyaichi, Tomimori, Suzuki, & Yamada, 1992) Kaempferia parviflora Wall. ex Baker 5,7-Dimethoxyflavone (77), Tetramethyllueteonin (78), Tri methyl apigenin (79), 5-Hydroxy-7-methoxyflavone (80), Avian influenza virus (H5N1) (Sornpet, Potha, Tragoolpua, & Pringproa, 2017) Curcuma longa L. Curcumin(diferuloylmethane) (9) H5N1 (Sornpet et al., 2017) Ginkgo biloba L., Cephalotaxus harringtonia K. Ginkgetin (81) Influenza virus (Miki et al., 2007) Houttuynia cordata Thunb. Quercetin 3-rhamnoside (82) Influenza virus (Choi, Song, Park, & Kwon, 2009) Tripterygium regelii Sprague &Takeda Celastrol (83) to date that needs to be controlled as soon as possible. non-structural proteins (3-chymotrypsin-like protease, papain-like protease, helicase, and RdRP) and accessory proteins coded by SARS-CoV-2 genome are needed to be explored. Usually, natural products could be a safe, secure, and dependable source to find drugs responsible for controlling the current pandemic. Protease and RNA polymerase inhibitors known to be active against SARS and MERS are also required to be explored. Different compounds (flavonoids, polyphenols, alkaloids, proanthocyanidins, and terpenoids), which are already known to have antiviral activities, need to be rapidly screened for the treatment of SARS-CoV-2 infected patients. In the context of not having proven medication of COVID19, patients depend on supportive care and symptomatic therapy. Hence, many herbal extract and natural products may help to treat the symptoms associated with SARS-CoV-2 infection. Search for antiviral activity in higher plant extracts Identification of potent COVID-19 main protease (M pro ) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: Using structure-based drug discovery approach Investigation of medicinal plants of Togo for antiviral and antimicrobial activities Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture Industrial natural product chemistry for drug discovery and development In vitro compartmentalization by double emulsions: Sorting and gene enrichment by fluorescence activated cell sorting The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: Future perspectives Hepatitis C virus and natural compounds: A new antiviral approach? Viruses, 4 Coronavirus disease 2019 (COVID-19) -Symptoms Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes Specific targets for antiviral drugs Antivirals and antiviral strategies Approved antiviral drugs over the past 50 years Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion Medicinal plant analysis: A historical and regional discussion of emergent complex techniques An in vitro compartmentalization-based method for the selection of bondforming enzymes from large libraries Antiviral activity of an extract derived from roots of Eleutherococcus senticosus Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction Antiviral activity of glycyrrhizic acid derivatives against SARS−coronavirus The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan Nucleoside natural products and related analogs with potential therapeutic properties as antibacterial and antiviral agents Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors Inhibition of SARS-CoV 3CL protease by flavonoids Antibacterial, antifungal, antiviral, and anthelmintic activities of medicinal plants of Nepal selected based on ethnobotanical evidence Potential inhibitor of COVID-19 main protease (M pro ) from several medicinal plant compounds by molecular docking study In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex Viral infectious disease and natural products with antiviral activity Immunomodulatory and anti-SARS activities of Houttuynia cordata Identification of natural compounds with antiviral activities against SARS-associated coronavirus Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds Fisetin and rutin as 3C protease inhibitors of enterovirus A71 Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines Lab-on-achip screening of methamphetamine and pseudoephedrine in samples from clandestine laboratories Drug treatment options for the 2019-new coronavirus (2019-nCoV) Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs Emerging novel coronavirus (2019-nCoV)-Current scenario, evolutionary perspective based on genome analysis and recent developments Anti-influenza virus activity of biflavonoids Coumarin: An emerging antiviral agent Plant serine protease inhibitor (SPI): A potent player with bactericidal, fungicidal, nematicidal and antiviral properties Anti-neuraminidase bioactives from Manggis Hutan (Garcinia celebica L.) leaves: Partial purification and molecular characterization Antiviral potentials of medicinal plants In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava Exploring the binding mechanism and accessible angle of SARS-CoV-2 spike and ACE2 by molecular dynamics simulation and free energy calculation Development of natural product drugs in a sustainable manner. Brief for GSDR 2015 The signaling pathways, and therapeutic targets of antiviral agents: Focusing on the antiviral approaches and clinical perspectives of Anthocyanins in the Management of Viral Diseases Screening of Nepalese medicinal plants for antiviral activity Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins Redeploying plant defences Inhibitors of HIV-1 replication that inhibit HIV integrase. Proceedings of the National Academy of Sciences of the United States of America Going global -Travel and the 2019 novel coronavirus Novel proteins in emulsions using in vitro compartmentalization SARS-CoV 3CL pro inhibitory effects of quinonemethide triterpenes from Tripterygium regelii Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNAdependent RNA polymerase Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection Medicinal plants of Tamil Nadu (Southern India) are a rich source of antiviral activities Immunostimulant properties of Heracleum maximum Bartr Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) Bioactive natural compounds against human coronaviruses: A review and perspective Supporting Information section at the end of this article. How to cite this article Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review The authors declare that there is no conflict of interest regarding the publication of this paper.